LATISSE® (bimatoprost ophthalmic solution) is a revolutionary prescription only product licenced (by the FDA, US) for eyelash hypotrichosis (inadequate or not enough eyelashes). It is proven stimulate growth of fuller, darker eyelashes.
Although LATISSE® is a treatment for inadequate or not enough eyelashes, it was originally developed for glaucoma through years of research by Allergan, a pharmaceutical leader with expertise in eye care products. It was found to increase lash growth when applied to the lid margin.
Results will may vary from one patient to the next and can take up to 16 weeks for maximum effects to be noticed.
Consultation + 1 months product supply - from £100